Attenuation of the acute amnestic effect of ethanol by ifenprodil: Comparison with ondansetron and dizocilpine

Fundamental and Clinical Pharmacology

Volumn 14, Issue 2, 2000, Pages 125-131

  Napiórkowska Pawlak, Dorota ^a   Malinowska, Barbara ^a   Pawlak, Robert ^a   Buczko, Włodzimierz ^a   Göthert, Manfred ^b  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^b UNIVERSITY OF BONN   (Germany)

Author keywords

Dizocilpine; Ethanol; Ifenprodil; Ondansetron; Passive avoidance

Indexed keywords

ALCOHOL; DIZOCILPINE; IFENPRODIL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; ONDANSETRON; SEROTONIN 3 ANTAGONIST;

ALCOHOL CONSUMPTION; AMNESIA; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG MECHANISM; DRUG RECEPTOR BINDING; LATENT PERIOD; MALE; MOUSE; NONHUMAN; PASSIVE AVOIDANCE; PRIORITY JOURNAL;

EID: 0034118183     PISSN: 07673981     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1472-8206.2000.tb00400.x     Document Type: Article

References (38)

1. [1] Bliss T.V.P., Collingridge G.L., A synaptic model of memory: long-term potentiation in the hippocampus, Nature 361 (1993) 31-39.
2. 3 Receptors in the CNS, Springer-Verlag, Berlin Heidelberg, 1997, p. 409.
3. [3] Fontana D.J., Daniels S.E., Henderson C., Eglen R.M., Wong E.H.F., Ondansetron improves cognitive performance in the Morris water maze spatial navigation task, Psychopharmacology 120 (1995) 409-417.
4. 3 receptors but not by N-methyl-D-aspartate receptor complex, Brain Res. 706 (1996) 227-232.
5. 3 receptor antagonist, Behav. Brain. Res. 82 (1997) 185-194.
6. [6] Pitsikas N., Borsini F., Different effects of tropisetron and ondansetron in learning and memory paradigms, Pharmacol. Biochem. Behav. 56 (1997) 571-576.
7. [7] Grant K.A., Emerging neurochemical concepts in the actions of ethanol at ligand-gated ion channels, Behav. Pharmacol. 5 (1994) 383-404.
8. [8] Lovinger D.M., Alcohols and neurotransmitter gated ion channels: past, present and future, Naunyn-Schmiedeberg's Arch. Pharmacol. 356 (1997) 267-282.
9. [9] Lovinger D.M., White G., Weight F.F., Ethanol inhibits NMDA-activated ion current in hippocampal neurons, Science 243 (1989) 1721-1724.
10. [10] Hoffman P.L, Rabe C.S., Moses F., Tabakoff B., N-methyl-D-aspartate receptors and ethanol: inhibition of calcium flux and cyclic GMP production, J. Neurochem. 52 (1989) 1937-1940.
11. [11] Göthert M., Fink K., Inhibition of N-methyl-D-aspartate (NMDA) and L-glutamate-induced noradrenaline and acetylcholine release in the rat brain by ethanol, Naunyn-Schmiedeberg's Arch. Pharmacol. 340 (1989) 516-521.
12. [12] Simson P.E., Criswell H.E., Johnson K.B., Hicks R.E., Breese G.R., Ethanol inhibits NMDA-evoked electrophysiological activity in vivo, J. Pharmacol. Exp. Ther. 257 (1991) 225-231.
13. 3 receptor-mediated ion current in neuroblastoma cells and isolated adult mammalian neurons, Mol. Pharmacol. 40 (1991) 263-270.
14. 14C-guanidinium influx in N1E-115 neuroblastoma cells, Naunyn-Schmiedeberg's Arch. Pharmacol. 352 (1995) 149-156.
15. 3 antagonist ondansetron on voluntary ethanol intake in rats and mice maintained on a limited access procedure, Psychopharmacology 117 (1995) 479-485.
16. 3 Receptors in the CNS, Springer-Verlag, Berlin Heidelberg, 1997, p. 587.
17. [17] Gotti B., Duverger D., Bertin J., Carter C., Dupont R., Frost J. et al., Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents. I. Evidence for efficacy in models of focal cerebral ischemia, J. Pharmacol. Exp. Ther. 247 (1988) 1211-1221.
18. [18] Carter C., Rivy J.P., Scatton B., Ifenprodil and SL 82.0715 are antagonists at the polyamine site of the N-methyl-D-aspartate (NMDA) receptor, Eur. J. Pharmacol. 164 (1989) 611-612.
19. 3 receptor, Neuropharmacol. 34 (1995) 621-629.
20. 2 binding sites, Naunyn-Schmiedeberg's Arch. Pharmacol. 354 (1996) 245-252.
21. 3 receptor cation channels by ifenprodil in excised patches of N1E-115 cells, Naunyn-Schmiedeberg's Arch. Pharmacol. 358 (1998) 145-152.
22. [22] Fink K., Göthert M., Both ethanol and ifenprodil inhibit NMDA-evoked release of various neurotransmitters at different, yet proportional potency: potential relation to NMDA receptor subunit composition, Naunyn-Schmiedeberg's Arch. Pharmacol. 354 (1996) 312-319.
23. [23] Lovinger D.M., Developmental decrease in ethanol inhibition of N-methyl-D-aspartate receptors in rat neocortical neurons: relation to the action of ifenprodil, J. Pharmacol. Exp. Ther. 274 (1995) 164-172.
24. [24] Buczko W., Malinowska B., Pawlak D.G, Pawlak R., Göthert M., Ifenprodil influences changes in mice behaviour related to acute and chronic ethanol administration, Naunyn-Schmiedeberg's Arch. Pharmacol. 358 (Suppl. 1) (1998) R186.
25. [25] Malinowska B., Pawlak D.G., Godlewski G., Buczko W., Göthert M., Ifenprodil influences ethanol-related behaviour in mice, Naunyn-Schmiedeberg's Arch. Pharmacol. 356 (1997) R56.
26. [26] Nagatani T., Yamamoto T., Takao K., Hashimoto S., Kasahara K., Sugihara T., Ueki S., Pharmacological profile of a potential anxiolytic: AP159, a new benzothieno-pyridine derivative, Psychopharmacology 104 (1991) 432-438.
27. [27] Bammer G., Chesher G.B., An analysis of some effects of ethanol on performance in a passive avoidance task, Psychopharmacology 77 (1982) 66-73.
28. [28] Castellano C., Pavone F., Effects of ethanol on passive avoidance behavior in mouse: Involvement of GABAergic mechanisms, Pharmacol. Biochem. Behav. 29 (1988) 321-324.
29. [29] Danysz W., Wróblewski J.T., Amnesic properties of glutamate receptor antagonists, Neurosci. Res. Commun. 5 (1989) 9-18.
30. [30] Parada-Turska J., Turski W.A., Excitatory amino acid antagonists and memory: effect of drugs acting at N-methyl-D-aspartate receptors in learning and memory tasks, Neuropharmacology 29 (1990) 1111-1116.
31. [31] Venable N., Kelly P.H., Effects of NMDA receptor antagonists on passive avoidance learning and retrieval in rats and mice, Psychopharmacology 100 (1990) 215-221.
32. [32] Perrault G., Morel E., Joly D., Sanger D.J., Zivkovic B., Differential neuropsychopharmacological profiles of NMDA antagonists: Ifenprodil-like, PCP-like and CPP-like compound, Eur. J. Pharmacol. 183 (1990) 942.
33. [33] Erakovic V., Zupan G., Mrsic J., Simonie A., Varljen J., The influence of nicardipine and ifenprodil on the brain free arachidonic acid level and behavior in hypoxia-exposed rats, Prog. Neuro-Psychopharmacol. Biol. Psychiat. 21 (1997) 633-647.
34. [34] Sanger D.J., Joly D., Effects of NMDA receptor antagonists and sigma ligands on the acquisition of conditioned fear in mice, Psychopharmacology 104 (1991) 27-34.
35. [35] Ginski M.J., Witkin J.M., Sensitive and rapid behavioral differentiation of N-methyl-D-aspartate receptor antagonists, Psychopharmacology 114 (1994) 573-582.
36. [36] Murata S., Kawasaki K., Common and uncommon behavioral effects of antagonists for different modulatory sites in the NMDA receptor/channel complex, Eur. J. Pharmacol. 239 (1993) 9-15.
37. [37] Perrault G., Morel E., Sanger D.J., Zivkovic B., Comparison of the pharmacological profiles of four NMDA antagonists, ifenprodil, SL 82.0715, MK-801 and CPP in mice, Br. J. Pharmacol. 95 (1989) 580P.
38. 3 receptor antagonists on ethanol-induced hyperlocomotion in mice, Pol. J. Pharmacol. 47 (1995) 293-297.